A new project to capture antimalarial drugs, leads and targets in the IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb)

Introduction: GtoPdb has been traditionally focused on the pharmacology associated with non-infectious diseases [1]. However, in October of 2017 we initiated a collaboration with Medicines for Malaria Venture (MMV) in Geneva, where we have been piloting the curation of antimalarial compounds and Plasmodium targets for approved drugs and the global portfolio of new clinical candidates and research leads [2]. This will provide explicit mappings between compounds and targets for current and new antimalarials.